200 related articles for article (PubMed ID: 32232524)
21. Hepatocellular carcinoma: comparative study among precontrast, artery-dominant, and delayed-contrast phase images at ultrafast CT.
Tobe K; Oyama K; Minami M; Amou K; Yoshida H; Kawaguchi N; Araki T; Sasaki Y
Radiat Med; 1996; 14(1):1-5. PubMed ID: 8725370
[TBL] [Abstract][Full Text] [Related]
22. Iodine material density images in dual-energy CT: quantification of contrast uptake and washout in HCC.
Pfeiffer D; Parakh A; Patino M; Kambadakone A; Rummeny EJ; Sahani DV
Abdom Radiol (NY); 2018 Dec; 43(12):3317-3323. PubMed ID: 29774382
[TBL] [Abstract][Full Text] [Related]
23. Detecting hepatocellular carcinoma: value of unenhanced or arterial phase CT imaging or both used in conjunction with conventional portal venous phase contrast-enhanced CT imaging.
Oliver JH; Baron RL; Federle MP; Rockette HE
AJR Am J Roentgenol; 1996 Jul; 167(1):71-7. PubMed ID: 8659425
[TBL] [Abstract][Full Text] [Related]
24. Distinguishing intrahepatic mass-forming biliary carcinomas from hepatocellular carcinoma by computed tomography and magnetic resonance imaging using the Bayesian method: a bi-center study.
Ichikawa S; Isoda H; Shimizu T; Tamada D; Taura K; Togashi K; Onishi H; Motosugi U
Eur Radiol; 2020 Nov; 30(11):5992-6002. PubMed ID: 32500195
[TBL] [Abstract][Full Text] [Related]
25. Value of precontrast and portal venous phases for evaluating atypical hepatocellular carcinoma mimicking arterioportal shunt.
Song M; Park HJ; Lee ES; Ahn HS; Park SB
Eur J Radiol; 2021 Oct; 143():109933. PubMed ID: 34492626
[TBL] [Abstract][Full Text] [Related]
26. Moderate versus high concentration of contrast material for aortic and hepatic enhancement and tumor-to-liver contrast at multi-detector row CT.
Awai K; Inoue M; Yagyu Y; Watanabe M; Sano T; Nin S; Koike R; Nishimura Y; Yamashita Y
Radiology; 2004 Dec; 233(3):682-8. PubMed ID: 15486215
[TBL] [Abstract][Full Text] [Related]
27. Evaluation of Texture Analysis Parameter for Response Prediction in Patients with Hepatocellular Carcinoma Undergoing Drug-eluting Bead Transarterial Chemoembolization (DEB-TACE) Using Biphasic Contrast-enhanced CT Image Data: Correlation with Liver Perfusion CT.
Kloth C; Thaiss WM; Kärgel R; Grimmer R; Fritz J; Ioanoviciu SD; Ketelsen D; Nikolaou K; Horger M
Acad Radiol; 2017 Nov; 24(11):1352-1363. PubMed ID: 28652049
[TBL] [Abstract][Full Text] [Related]
28. Utility of volumetric contrast-enhanced and diffusion-weighted MRI in differentiating between common primary hypervascular liver tumors.
Zarghampour M; Fouladi DF; Pandey A; Ghasabeh MA; Pandey P; Varzaneh FN; Khoshpouri P; Shao N; Pan L; Grimm R; Kamel IR
J Magn Reson Imaging; 2018 Oct; 48(4):1080-1090. PubMed ID: 29630756
[TBL] [Abstract][Full Text] [Related]
29. Detection of hypervascular hepatocellular carcinoma by dynamic magnetic resonance imaging with double-echo chemical shift in-phase and opposed-phase gradient echo technique: comparison with dynamic helical computed tomography imaging with double arterial phase.
Noguchi Y; Murakami T; Kim T; Hori M; Osuga K; Kawata S; Okada A; Sugiura T; Tomoda K; Narumi Y; Nakamura H
J Comput Assist Tomogr; 2002; 26(6):981-7. PubMed ID: 12488747
[TBL] [Abstract][Full Text] [Related]
30. Arterio-portal shunts in the cirrhotic liver: perfusion computed tomography for distinction of arterialized pseudolesions from hepatocellular carcinoma.
Fischer MA; Marquez HP; Gordic S; Leidner B; Klotz E; Aspelin P; Alkadhi H; Brismar TB
Eur Radiol; 2017 Mar; 27(3):1074-1080. PubMed ID: 27368924
[TBL] [Abstract][Full Text] [Related]
31. Applicability of multidimensional convolutional neural networks on automated detection of diverse focal liver lesions in multiphase CT images.
Chen Q; Zhu Y; Chen Y; Wang F; Hu X; Ye Y; Dou X; Huang Y; Deng L; Zhou W; Liang X; Hu H
Med Phys; 2023 May; 50(5):2872-2883. PubMed ID: 36441108
[TBL] [Abstract][Full Text] [Related]
32. Detection of hypervascular nodular hepatocellular carcinomas: value of triphasic helical CT compared with iodized-oil CT.
Choi BI; Lee HJ; Han JK; Choi DS; Seo JB; Han MC
AJR Am J Roentgenol; 1997 Jan; 168(1):219-24. PubMed ID: 8976949
[TBL] [Abstract][Full Text] [Related]
33. Computer-aided diagnosis of cirrhosis and hepatocellular carcinoma using multi-phase abdomen CT.
Nayak A; Baidya Kayal E; Arya M; Culli J; Krishan S; Agarwal S; Mehndiratta A
Int J Comput Assist Radiol Surg; 2019 Aug; 14(8):1341-1352. PubMed ID: 31062266
[TBL] [Abstract][Full Text] [Related]
34. Differentiation of Atypical Hepatocellular Carcinoma from Focal Nodular Hyperplasia: Diagnostic Performance of Contrast-enhanced US and Microflow Imaging.
Li W; Wang W; Liu GJ; Chen LD; Wang Z; Huang Y; Liu JY; Xie XY; Lu MD
Radiology; 2015 Jun; 275(3):870-9. PubMed ID: 25584708
[TBL] [Abstract][Full Text] [Related]
35. Small hepatocellular carcinoma in patients with chronic liver damage: prospective comparison of detection with dynamic MR imaging and helical CT of the whole liver.
Yamashita Y; Mitsuzaki K; Yi T; Ogata I; Nishiharu T; Urata J; Takahashi M
Radiology; 1996 Jul; 200(1):79-84. PubMed ID: 8657948
[TBL] [Abstract][Full Text] [Related]
36. Hepatocellular carcinoma: detection with triple-phase multi-detector row helical CT in patients with chronic hepatitis.
Laghi A; Iannaccone R; Rossi P; Carbone I; Ferrari R; Mangiapane F; Nofroni I; Passariello R
Radiology; 2003 Feb; 226(2):543-9. PubMed ID: 12563152
[TBL] [Abstract][Full Text] [Related]
37. Impact of intravenous contrast enhancement phase on target definition for hepatocellular carcinoma (HCC) and intrahepatic cholangiocarcinoma (IHC): Observations from patients enrolled on a prospective phase 2 trial.
Niska JR; Keane FK; Wolfgang JA; Hahn PF; Wo JY; Zhu AX; Hong TS
Pract Radiat Oncol; 2016; 6(1):e9-16. PubMed ID: 26598907
[TBL] [Abstract][Full Text] [Related]
38. Deep learning-assisted differentiation of pathologically proven atypical and typical hepatocellular carcinoma (HCC) versus non-HCC on contrast-enhanced MRI of the liver.
Oestmann PM; Wang CJ; Savic LJ; Hamm CA; Stark S; Schobert I; Gebauer B; Schlachter T; Lin M; Weinreb JC; Batra R; Mulligan D; Zhang X; Duncan JS; Chapiro J
Eur Radiol; 2021 Jul; 31(7):4981-4990. PubMed ID: 33409782
[TBL] [Abstract][Full Text] [Related]
39. Detection and characterization of focal liver lesions: a Japanese phase III, multicenter comparison between gadoxetic acid disodium-enhanced magnetic resonance imaging and contrast-enhanced computed tomography predominantly in patients with hepatocellular carcinoma and chronic liver disease.
Ichikawa T; Saito K; Yoshioka N; Tanimoto A; Gokan T; Takehara Y; Kamura T; Gabata T; Murakami T; Ito K; Hirohashi S; Nishie A; Saito Y; Onaya H; Kuwatsuru R; Morimoto A; Ueda K; Kurauchi M; Breuer J
Invest Radiol; 2010 Mar; 45(3):133-41. PubMed ID: 20098330
[TBL] [Abstract][Full Text] [Related]
40. A multi-scale, multi-region and attention mechanism-based deep learning framework for prediction of grading in hepatocellular carcinoma.
Wei J; Ji Q; Gao Y; Yang X; Guo D; Gu D; Yuan C; Tian J; Ding D
Med Phys; 2023 Apr; 50(4):2290-2302. PubMed ID: 36453607
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
